132 related articles for article (PubMed ID: 6190337)
21. [Beta-thromboglobulin--an indicator of thrombocyte activation in vivo].
Parízek M; Kubisz P; Holan J
Bratisl Lek Listy; 1985 Aug; 84(2):150-6. PubMed ID: 2411363
[No Abstract] [Full Text] [Related]
22. Platelet aggregation, beta-thromboglobulin and platelet factor 4 in diabetes mellitus and in patients with vasculopathy.
Fritschi J; Christe M; Lämmle B; Marbet GA; Berger W; Duckert F
Thromb Haemost; 1984 Dec; 52(3):236-9. PubMed ID: 6241750
[TBL] [Abstract][Full Text] [Related]
23. Plasma beta-thromboglobulin response to insulin-induced hypoglycemia in type I diabetic patients.
Monnier LH; Lachkar H; Richard JL; Colette C; Borgel D; Orsetti A; Mirouze J
Diabetes; 1984 Sep; 33(9):907-9. PubMed ID: 6205922
[TBL] [Abstract][Full Text] [Related]
24. [Thromboxane, beta-thromboglobulin and the degree of blood sugar control in type 1 diabetes mellitus].
Tanganelli I; Signorini AM; Gragnoli G
Boll Soc Ital Biol Sper; 1983 Jul; 59(7):897-902. PubMed ID: 6194801
[TBL] [Abstract][Full Text] [Related]
25. Beta-thromboglobulin and fibrinopeptide A in diabetes mellitus as markers of vascular damage.
Librenti MC; D'Angelo A; Micossi P; Garimberti B; Mannucci PM; Pozza G
Acta Diabetol Lat; 1985; 22(1):39-45. PubMed ID: 2408434
[TBL] [Abstract][Full Text] [Related]
26. Comparison of platelet function during exercise in normal subjects and coronary artery disease patients: Potential role of platelet activation in myocardial ischemia.
Mehta J; Mehta P
Am Heart J; 1982 Jan; 103(1):49-53. PubMed ID: 6172974
[TBL] [Abstract][Full Text] [Related]
27. Plasma beta-thromboglobulin, platelet factor 4, fibrinopeptide A, and other hemostatic functions during improved, short-term glycemic control in diabetes mellitus.
Rosove MH; Frank HJ; Harwig SS
Diabetes Care; 1984; 7(2):174-9. PubMed ID: 6203689
[TBL] [Abstract][Full Text] [Related]
28. Relationships between metabolic and hemostatic variables in uncomplicated diabetes.
Vergani C; Bettale G; Mari D; Mannucci PM
Acta Diabetol Lat; 1981; 18(3):199-206. PubMed ID: 6171128
[TBL] [Abstract][Full Text] [Related]
29. Vascular prostacyclin, platelet sensitivity to prostaglandins and platelet-specific proteins in diabetes mellitus. Analysis of type of diabetes, state of metabolic control and diabetic microangiopathy.
Schernthaner G; Sinzinger H; Silberbauer K; Freyler H; Mühlhauser I; Kaliman J
Horm Metab Res Suppl; 1981; 11():33-43. PubMed ID: 6459282
[No Abstract] [Full Text] [Related]
30. Elevated beta-thromboglobulin levels and circulating platelet aggregates in diabetic microangiopathy.
Preston FE; Ward JD; Marcola BH; Porter NR; Timperley WR; O'Malley BC
Lancet; 1978 Feb; 1(8058):238-40. PubMed ID: 74664
[TBL] [Abstract][Full Text] [Related]
31. Moderate exercise increases platelet function in type I diabetic patients without severe angiopathy and in good control.
Trovati M; Anfossi G; De Facis R; Mularoni E; Massucco P; Cavalot F; Burzacca S; Mattiello L; Lucchina PG
Diabetes Care; 1992 Nov; 15(11):1742-6. PubMed ID: 1468311
[TBL] [Abstract][Full Text] [Related]
32. Plasma beta-thromboglobulin is correlated with platelet adhesiveness to bovine endothelium in patients with diabetes mellitus.
Rosove MH; Frank HJ; Harwig SS; Berliner J
Thromb Res; 1985 Jan; 37(2):251-8. PubMed ID: 2579451
[TBL] [Abstract][Full Text] [Related]
33. [Changes in platelet function and their correlation with the blood lipid picture in diabetic vasculopathies].
Ferri GM; Leri O; Emiliozzi P; Lucisano V; De Marco A; Amoroso A
Recenti Prog Med; 1986 May; 77(5):233-6. PubMed ID: 2426744
[No Abstract] [Full Text] [Related]
34. [Evaluation of various parameters of platelet function in subjects with type II diabetes mellitus. Methodologic study of the changes in PF4 and beta-TG].
Ferri GM; Afeltra A; Caccavo D; Amoroso A
Recenti Prog Med; 1986 Jan; 77(1):31-2. PubMed ID: 2422709
[No Abstract] [Full Text] [Related]
35. Platelet hyperfunction in patients with chronic airways obstruction.
Cordova C; Musca A; Violi F; Alessandri C; Perrone A; Balsano F
Eur J Respir Dis; 1985 Jan; 66(1):9-12. PubMed ID: 2579841
[TBL] [Abstract][Full Text] [Related]
36. Effects of somatostatin on the behaviour of thromboxane B2 and beta-thromboglobulin in type I diabetes.
Gragnoli G; Signorini AM; Tanganelli I
Acta Endocrinol (Copenh); 1985 May; 109(1):104-7. PubMed ID: 2408435
[TBL] [Abstract][Full Text] [Related]
37. Effect of glycaemic control, metformin and gliclazide on platelet density and aggregability in recently diagnosed type 2 (non-insulin-dependent) diabetic patients.
Collier A; Watson HH; Patrick AW; Ludlam CA; Clarke BF
Diabete Metab; 1989; 15(6):420-5. PubMed ID: 2534084
[TBL] [Abstract][Full Text] [Related]
38. Factors contributing to platelet hyperactivity in diabetes mellitus.
Dupuy E; Guillausseau PJ
Adv Exp Med Biol; 1984; 164():105-10. PubMed ID: 6229977
[No Abstract] [Full Text] [Related]
39. Effects of prazosin on platelet aggregation and plasma beta-thromboglobulin in essential hypertension.
Ikeda T; Nonaka Y; Goto A; Ishii M
Clin Pharmacol Ther; 1985 Jun; 37(6):601-5. PubMed ID: 2408807
[TBL] [Abstract][Full Text] [Related]
40. [Clinical significance of the radioimmunological determination of beta-thromboglobulin and platelet factor 4].
Schernthaner G; Silberbauer K; Mühlhauser I; Willvonseder R
Acta Med Austriaca Suppl; 1979; 6():375-9. PubMed ID: 95543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
